CN101622000B - 合成glyt-1抑制剂的方法 - Google Patents
合成glyt-1抑制剂的方法 Download PDFInfo
- Publication number
- CN101622000B CN101622000B CN200880006900XA CN200880006900A CN101622000B CN 101622000 B CN101622000 B CN 101622000B CN 200880006900X A CN200880006900X A CN 200880006900XA CN 200880006900 A CN200880006900 A CN 200880006900A CN 101622000 B CN101622000 B CN 101622000B
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- alkyl
- halogen
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *S(c(cc1)cc(C(O)=C)c1F)(=O)=O Chemical compound *S(c(cc1)cc(C(O)=C)c1F)(=O)=O 0.000 description 3
- NWXBHCBBFZOTOQ-UHFFFAOYSA-N CC(C)Oc(ccc(S(C)(=O)=O)c1)c1C(O)=O Chemical compound CC(C)Oc(ccc(S(C)(=O)=O)c1)c1C(O)=O NWXBHCBBFZOTOQ-UHFFFAOYSA-N 0.000 description 1
- ACBAHAXPEQHVHO-UHFFFAOYSA-N CS(c(cc1)cc(C(O)=O)c1F)(=O)=O Chemical compound CS(c(cc1)cc(C(O)=O)c1F)(=O)=O ACBAHAXPEQHVHO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07103485 | 2007-03-05 | ||
| EP07103485.4 | 2007-03-05 | ||
| PCT/EP2008/052244 WO2008107334A2 (en) | 2007-03-05 | 2008-02-25 | Process for the synthesis of glyt-1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101622000A CN101622000A (zh) | 2010-01-06 |
| CN101622000B true CN101622000B (zh) | 2012-07-04 |
Family
ID=39469606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200880006900XA Active CN101622000B (zh) | 2007-03-05 | 2008-02-25 | 合成glyt-1抑制剂的方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7812161B2 (enExample) |
| EP (1) | EP2131843B1 (enExample) |
| JP (1) | JP4745446B2 (enExample) |
| KR (1) | KR101143073B1 (enExample) |
| CN (1) | CN101622000B (enExample) |
| AT (1) | ATE532516T1 (enExample) |
| AU (1) | AU2008223915B2 (enExample) |
| BR (1) | BRPI0808570B8 (enExample) |
| CA (1) | CA2678630C (enExample) |
| ES (1) | ES2375585T3 (enExample) |
| IL (1) | IL200323A (enExample) |
| MX (1) | MX2009009065A (enExample) |
| WO (1) | WO2008107334A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5656474B2 (ja) | 2010-06-28 | 2015-01-21 | 関東化学株式会社 | 脂肪族光学活性フルオロアルコールの製造方法 |
| CN104628679B (zh) * | 2013-11-08 | 2018-02-09 | 江苏恩华药业股份有限公司 | Bitopertin的合成方法及其中间体 |
| CN106397312B (zh) * | 2015-07-31 | 2020-03-24 | 广东东阳光药业有限公司 | 一种制备glyt-1抑制剂的方法 |
| CN116212025B (zh) | 2020-01-09 | 2025-08-05 | 迪斯克医药公司 | 治疗红细胞生成性原卟啉病、x连锁原卟啉病或先天性红细胞生成性卟啉病的方法 |
| AU2021360172A1 (en) | 2020-10-13 | 2023-03-30 | Boehringer Ingelheim International Gmbh | Process of reworking |
| CN119768399A (zh) | 2022-08-24 | 2025-04-04 | 勃林格殷格翰国际有限公司 | GlyT-1抑制剂的可规模化制备方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006061135A1 (en) * | 2004-12-09 | 2006-06-15 | F. Hoffmann-La Roche Ag | Phenyl-piperazin methanone derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3992441A (en) * | 1972-12-26 | 1976-11-16 | Pfizer Inc. | Sulfamylbenzoic acids |
| US4480102A (en) * | 1982-07-23 | 1984-10-30 | The Dow Chemical Company | 2,3-Difluoro-5-(trifluoromethyl)pyridine and methods of making and using the same |
| ES2061953T3 (es) * | 1988-11-24 | 1994-12-16 | Akzo Nv | Un procedimiento para preparar una composicion farmaceutica. |
| DE4235155A1 (de) * | 1992-10-19 | 1994-04-21 | Basf Ag | Verfahren zur Herstellung von Methylsulfonylbenzoesäuren |
| WO1999054284A1 (en) * | 1998-04-20 | 1999-10-28 | Fujisawa Pharmaceutical Co., Ltd. | Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase |
| DE10112040A1 (de) | 2001-03-14 | 2002-10-02 | Aventis Pharma Gmbh | Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten |
| GB0227240D0 (en) * | 2002-11-21 | 2002-12-31 | Glaxo Group Ltd | Compounds |
| NZ544820A (en) * | 2003-08-11 | 2009-02-28 | Hoffmann La Roche | Piperazine with or-substituted phenyl group and their use as GlyT1 inhibitors |
| CN101356163A (zh) * | 2005-01-06 | 2009-01-28 | 弗·哈夫曼-拉罗切有限公司 | 作为甘氨酸转运体1(GlyT-1)抑制剂用于治疗神经学和神经精神病学障碍的硫烷基取代的苯甲酮化合物 |
| CA2593463C (en) * | 2005-01-07 | 2013-10-08 | F. Hoffmann-La Roche Ag | [4-(heteroaryl) piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| CN101218350B (zh) * | 2005-07-08 | 2011-08-31 | 弗·哈夫曼-拉罗切有限公司 | 1,1,1-三氟丙酮的不对称还原反应 |
-
2008
- 2008-02-25 BR BRPI0808570A patent/BRPI0808570B8/pt active IP Right Grant
- 2008-02-25 ES ES08709206T patent/ES2375585T3/es active Active
- 2008-02-25 AT AT08709206T patent/ATE532516T1/de active
- 2008-02-25 EP EP08709206A patent/EP2131843B1/en active Active
- 2008-02-25 KR KR1020097018418A patent/KR101143073B1/ko active Active
- 2008-02-25 AU AU2008223915A patent/AU2008223915B2/en active Active
- 2008-02-25 MX MX2009009065A patent/MX2009009065A/es active IP Right Grant
- 2008-02-25 WO PCT/EP2008/052244 patent/WO2008107334A2/en not_active Ceased
- 2008-02-25 CN CN200880006900XA patent/CN101622000B/zh active Active
- 2008-02-25 JP JP2009552166A patent/JP4745446B2/ja active Active
- 2008-02-25 CA CA2678630A patent/CA2678630C/en active Active
- 2008-02-27 US US12/038,006 patent/US7812161B2/en active Active
-
2009
- 2009-08-10 IL IL200323A patent/IL200323A/en active IP Right Grant
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006061135A1 (en) * | 2004-12-09 | 2006-06-15 | F. Hoffmann-La Roche Ag | Phenyl-piperazin methanone derivatives |
Non-Patent Citations (2)
| Title |
|---|
| Harald Suhr.Der EinfluB der austretenden Grupppe auf die Geschwindigkeit von nucleophilen aromatischen Substitutionen.《Chemische Berichte》.1963,第97卷参见第3268-3276页. * |
| Jerry March.aromatic nucleophilic substitute.《Advanced Organic Chemistry:reactions,mechanisms, and structure》.1992,(第4版),参见第652-653页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2131843A2 (en) | 2009-12-16 |
| AU2008223915A1 (en) | 2008-09-12 |
| BRPI0808570B1 (pt) | 2020-09-15 |
| BRPI0808570B8 (pt) | 2021-05-25 |
| IL200323A0 (en) | 2010-04-29 |
| JP2010520251A (ja) | 2010-06-10 |
| WO2008107334A3 (en) | 2008-10-23 |
| US7812161B2 (en) | 2010-10-12 |
| JP4745446B2 (ja) | 2011-08-10 |
| CN101622000A (zh) | 2010-01-06 |
| ES2375585T3 (es) | 2012-03-02 |
| ATE532516T1 (de) | 2011-11-15 |
| EP2131843B1 (en) | 2011-11-09 |
| BRPI0808570A2 (pt) | 2014-09-02 |
| WO2008107334A2 (en) | 2008-09-12 |
| MX2009009065A (es) | 2009-08-31 |
| CA2678630A1 (en) | 2008-09-12 |
| US20080221327A1 (en) | 2008-09-11 |
| KR20090110368A (ko) | 2009-10-21 |
| KR101143073B1 (ko) | 2012-05-08 |
| IL200323A (en) | 2013-11-28 |
| AU2008223915B2 (en) | 2013-05-02 |
| CA2678630C (en) | 2015-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101622000B (zh) | 合成glyt-1抑制剂的方法 | |
| JP5805880B2 (ja) | １−（４−（４−（３，４−ジクロロ−２−フルオロフェニルアミノ）−７−メトキシキナゾリン−６−イルオキシ）ピペリジン−１−イル）−プロパ−２−エン−１−オン塩酸塩の製造方法および該方法で用いられる中間体 | |
| JP2018526340A (ja) | 細胞毒性ベンゾジアゼピン誘導体の調製方法 | |
| TWI438188B (zh) | 用於合成醫藥品之中間化合物的製造方法 | |
| CA2719526A1 (en) | Conversion of tryptophan into .beta.-carboline derivatives | |
| KR20100103646A (ko) | ６치환된１（２ｈ）이소퀴놀리논의 제조 방법 | |
| JP6947354B2 (ja) | リナグリプチンの製造法 | |
| CN1310884C (zh) | 对映体纯的n－甲基－n－[(1s)－1－苯基－2－((3s)－3－羟基吡咯烷－1－基)乙基]－2，2－二苯基乙酰胺的制备方法 | |
| EP2332908A1 (en) | Method for purifying aminoacetylpyrrolidinecarbonitrile derivative and salt thereof | |
| WO2023226900A1 (zh) | 2-(哌嗪-2-基)乙腈类衍生物及其制备方法和应用 | |
| JP3243072B2 (ja) | ２，５−二置換ピリジン類の製造方法 | |
| CN119707838B (zh) | 一种（s）-2-哌嗪基乙腈或其盐的合成方法 | |
| EP2540717B1 (en) | Lamivudine oxalate and preparation method thereof | |
| KR100302349B1 (ko) | 시사프라이드의 제조방법 | |
| JP4441260B2 (ja) | ４−アミノ−４−フェニルピペリジン類の製造方法 | |
| CN104768930B (zh) | 光学活性双环脲化合物的制造方法 | |
| CN103755624A (zh) | 一种哌啶衍生物的合成方法 | |
| JPWO2010079605A1 (ja) | 高純度１−ベンジル−３−アミノピロリジンの製造方法 | |
| WO2005066124A1 (ja) | ピロリジン誘導体の製造法 | |
| HK40035144B (zh) | 两种化合物的制备方法 | |
| WO2009104557A1 (ja) | Ｎ－（３－ピロリジニル）グリシン誘導体の製造法 | |
| WO2020129877A1 (ja) | イソキノリンスルホニルクロリド酸付加塩及びその製造方法 | |
| KR20080076009A (ko) | Ｓ-(-)-암로디핀 또는 이의 염의 제조방법 및 이에사용되는 중간체 | |
| JP2009263272A (ja) | ヘテロ元素を有する脂環式アミノ酸誘導体およびその製造方法 | |
| JP2008273840A (ja) | ベンジルアミン誘導体の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |